Jiangsu Kanion Pharmaceutical Co.,Ltd.

¥12.73As of Sun 8 Nov 2026, 12:00 UTC
SSE:600557Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.09%)
Div yield —
ROE 6.26%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.42
PE TTM 22.72
TSR TTM (14.85%)
Mkt cap ¥7.207B
ROIC 5.63%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
24.74%
(72.07%)
Hold 1|12|10|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.16
0.16
0.16
39.45%
24.30%
16.52%
5.93%
Revenue¥M
366.9
359.3
353.6
359.2
12.07%
4.06%
(1.33%)
1.24%
Peers (US$1.080B)
Cap (US$)
PE
1.085B
14.18x
1.068B
106.9x
1.079B
48.36x
Capital
TTM
5Y
10Y
Leveragex
0.945
(0.198)
(0.187)
EBIT/Intx
0.978
0.174
0.185
Own earn%
(44.94)
(59.40)
(55.86)
Sh yield%
46.42
12.39
15.07
Owners
Insiders/Inst%
6.94
59.98
Short interest%
1.27
SBC / revenue%
2.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
15–21
$1 testx
−0.1
Incr. ROIC%
3